XIAP and hepatocellular carcinoma: In order to explore the potential anti-HCC mechanism of BETd-260, we analyzed the effect of BETd-260 on expression of several known downstream targets of BET proteins, including Bcl-2, Mcl-1 and c-Myc, as well as XIAP (5, 6, 14).